CS221828B2 - Method of making the new ergoline derivatives - Google Patents

Method of making the new ergoline derivatives Download PDF

Info

Publication number
CS221828B2
CS221828B2 CS812388A CS238881A CS221828B2 CS 221828 B2 CS221828 B2 CS 221828B2 CS 812388 A CS812388 A CS 812388A CS 238881 A CS238881 A CS 238881A CS 221828 B2 CS221828 B2 CS 221828B2
Authority
CS
Czechoslovakia
Prior art keywords
group
methyl
urea
day
carbonyl
Prior art date
Application number
CS812388A
Other languages
Czech (cs)
English (en)
Inventor
Patricia Salvati
Anna M Caravaggi
Aldemio Temperilli
Cermano Bosisio
Osvaldo Sapini
Salle Enrico Di
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of CS221828B2 publication Critical patent/CS221828B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS812388A 1980-04-03 1981-03-31 Method of making the new ergoline derivatives CS221828B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8011234 1980-04-03

Publications (1)

Publication Number Publication Date
CS221828B2 true CS221828B2 (en) 1983-04-29

Family

ID=10512588

Family Applications (1)

Application Number Title Priority Date Filing Date
CS812388A CS221828B2 (en) 1980-04-03 1981-03-31 Method of making the new ergoline derivatives

Country Status (7)

Country Link
JP (1) JPS56156279A (da)
BE (1) BE888243A (da)
CS (1) CS221828B2 (da)
HU (1) HU183382B (da)
SU (1) SU1053756A3 (da)
UA (1) UA6027A1 (da)
ZA (1) ZA812103B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2173189B (en) * 1985-02-21 1988-04-27 Maruko Pharmaceutical Co Ergoline derivatives and salts thereof and pharmaceutical compositions thereof
JPS6445652U (da) * 1987-09-16 1989-03-20
JPH01123664U (da) * 1988-02-16 1989-08-23
EP1925616A1 (en) * 2006-10-26 2008-05-28 LEK Pharmaceuticals D.D. Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline

Also Published As

Publication number Publication date
JPS6213956B2 (da) 1987-03-30
SU1053756A3 (ru) 1983-11-07
UA6027A1 (uk) 1994-12-29
ZA812103B (en) 1982-04-28
HU183382B (en) 1984-04-28
JPS56156279A (en) 1981-12-02
BE888243A (fr) 1981-10-02

Similar Documents

Publication Publication Date Title
SU1400509A3 (ru) Способ получени N-(4-пиперидинил)-бициклических производных 2-имидазоламина или их кислотно-аддитивных солей
US9708255B2 (en) (bis)urea and (bis)thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders
US4167565A (en) Adenosine-5'-carboxamides and method of use
SU1400508A3 (ru) Способ получени производных арилтиазолов
US2920012A (en) Therapeutic compositions for inhibiting carbonic anhydrase activity
HU229404B1 (en) 1,2-annelated quinoline derivatives
SI9300616A (en) Enzyme inhibitors
NO854825L (no) Renininhiberende dipeptider og fremgangsmaate til fremstilling derav.
WO1991013071A1 (de) Neue trisubstituierte pyrrole, verfahren zur ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
SE430604B (sv) Nya derivat av 5-fenyl-prolin och forfarande for deras framstellning
SE451015B (sv) Substituerade moranolinderivat
KR20150004441A (ko) Ｐｄｅ４의 바이사이클릭 헤테로아릴 억제제
EP0236734A2 (de) Durch schwefelhaltigen Gruppen substituierte 5-Amino-4-hydroxyvalerylderivate
JPH10512251A (ja) 骨粗鬆症の治療に有用なインドール誘導体
EP0374097A2 (de) Verwendung von Peptidisosteren als retrovirale Proteasehemmer
CS221828B2 (en) Method of making the new ergoline derivatives
KR930007431B1 (ko) 경구용 활성 레닌 억제제
RU2268889C2 (ru) Применение производных цистеина для получения лекарственного средства, предназначенного для лечения патологий, возникающих вследствие образования гетеротримерного протеина g
KR900009022B1 (ko) 비 펩타이드성 레닌 억제제
SK279136B6 (sk) Hydrazóny, farmaceutické prípravky s ich obsahom a
US5221667A (en) Renin inhibiting peptides having an α-heteroatom amino acid at the P3 position
DK148686B (da) Analogifremgangsmaade til fremstilling af ergolinderivater
Goto et al. Novel histamine H3 receptor antagonists: synthesis and evaluation of formamidine and S-methylisothiourea derivatives
KR100251570B1 (ko) 면역조절제 아자스피란
SE455096B (sv) 4,5,6,7-tetrahydrotiazolo /5,4-c/-pyridinderivat, forfarande for framstellning derav samt farmaceutisk komposition innehallande nemnda derivat